Targeting of PI3K/AKT signaling and DNA damage response in acute myeloid leukemia: a novel therapeutic strategy to boost chemotherapy response and overcome resistance

Resistance of cancer patients to DNA damaging radiation therapy and chemotherapy remains a major problem in the clinic. The current review discusses the molecular mechanisms of therapy resistance in acute myeloid leukemia (AML) conferred by cooperative chemotherapy-induced DNA damage response (DDR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Estruch, Montserrat, Vittori, Camilla, Montesinos, Teresa Muñoz, Reckzeh, Kristian, Theilgaard-Mönch, Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2021
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992442/
https://www.ncbi.nlm.nih.gov/pubmed/35582388
http://dx.doi.org/10.20517/cdr.2021.76

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992442/
https://www.ncbi.nlm.nih.gov/pubmed/35582388
http://dx.doi.org/10.20517/cdr.2021.76

Ejemplares similares